Navigation Links
Moffitt Cancer Center researchers analyze how Spanish smoking relapse booklets are distributed
Date:5/16/2013

Researchers from Moffitt Cancer Center and the University of South Florida have evaluated how Florida health care and social service agencies distribute "Libres para Siempre" ("Forever Free"), a Spanish smoking relapse prevention booklet series.

Their analysis found that 10 agencies distributed the booklets actively and passively, but those methods may not have helped the material reach its intended audience, Spanish-speaking smokers who have quit but are at risk for relapse.

Their study appeared in a March issue of the Journal of Cancer Education.

"Previous research suggests that although the current smoking rates among Hispanics are lower than the overall prevalence in the United States, Hispanic smokers are less likely to quit successfully or to use smoking cessation aids," said study co-author Vani Nath Simmons, Ph.D., assistant member of the Health Outcomes and Behavior Program at Moffitt. "Consequently, there is a great need to increase the availability of culturally relevant tobacco information in Spanish. The first aim of this study was to evaluate the distribution process of 'Libres para Siempre' to identify the strategies, methods and barriers to distribution. Secondly, we wanted feedback from the agencies on the booklets' quality and usefulness."

The researchers noted that the relapse rate for self-quitters is 95 to 98 percent and that Hispanic smokers are less likely than their non-Hispanic white counterparts to be advised to quit smoking.

"Forever Free," a series of self-help booklets developed at Moffitt to help smokers, who have quit from relapsing, was found to be cost effective and beneficial for reducing smoking relapse among English speakers. To increase its reach to more diverse populations, the "Forever Free" booklets were adapted to create a culturally appropriate Spanish version, "Libres para Siempre." This study examined how health care and social service agencies in Florida disseminated those Spanish booklets.

"To truly make an impact, we needed to make sure the booklets were getting into the hands of the intended audience," Simmons said.

Active distribution included in-person presentation of the booklets at community events or use of the booklet as part of counseling or tobacco-related classes. Passive distribution included displaying the booklet at agency lobbies, events and health fairs.

There were barriers to optimal distribution. For example, the booklets are a set of eight. Some agencies distributed booklets individually. Some distributors gave booklets to those who may have been interested in quitting smoking, rather than those who had quit and were likely to relapse. The booklets target those in danger of relapse.

"Understanding how these booklets are used in the real world can lead to future research to test alternative distribution strategies," noted Simmons. "We determined that some agencies were unable to understand the distinction between interventions for initial smoking cessation and intervention as relapse prevention."

In evaluating the quality and usefulness of the booklets, agency representatives found them beneficial for their clients.

The authors concluded that the distribution process for "Libres para Siempre" could serve as a pilot study to evaluate strategies and methods of distribution, and find the best ways to reach those Hispanics needing relapse prevention materials.


'/>"/>

Contact: Kim Polacek
kim.polacek@moffitt.org
813-745-7408
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Cancer biorepository speeds clinical trials, drug development, Moffitt analysis shows
2. Deficiency in p53 anti-tumor protein delays DNA repair after radiation, Moffitt researchers say
3. Some minorities believe they are less likely to get cancer compared to whites, Moffitt study shows
4. 2-drug combo more effective in treating sarcomas, Moffitt Cancer Center study shows
5. Moffitt Cancer Center researchers discuss new frontiers in breast cancer screening
6. Moffitt Cancer Center researchers say 1 specific microrna promotes tumor growth and cancer spread
7. Moffitt Researchers help lead international efforts that find new genetic links to ovarian cancer
8. Moffitt researchers analyze HPV vaccination disparities among girls from low-income families
9. Moffitt Cancer Center researchers design small molecule to disrupt cancer-causing protein
10. Genetic risk strategies needed for young, black, female breast cancer patients, Moffitt study shows
11. Moffitt Cancer Center researchers study use of dasatinib for patients with high-risk MDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
Breaking Medicine Technology: